7 assets in Respiratory System Disorder

Therapeutic assets addressing Respiratory System Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Carboplatin Respiratory System Disorder	Nanfang Hospital, Southern Medical University	P3	BB (70)
Cis-Diamminedichloroplatinum Ii Respiratory System Disorder	Nanfang Hospital, Southern Medical University	P3	BB (66)
Adebrelimab Respiratory System Disorder	Nanfang Hospital, Southern Medical University	P2	CCC (53)
Etoposide Respiratory System Disorder	Nanfang Hospital, Southern Medical University	P2	CCC (53)
Blu-701 Respiratory System Disorder	Blueprint Medicines Corporation	P1	CC (43)
Osimertinib Respiratory System Disorder	Blueprint Medicines Corporation	P1	CC (43)
Pebezertinib Respiratory System Disorder	Blueprint Medicines Corporation	P1	CC (43)